#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    PIK3CA related overgrowth spectrum Hereditary neuropathic amyloidosis Hodgkin's disease Adrenoleukodystrophy Hepatitis B Hypoxic-ischaemic encephalopathy Kidney transplant rejection Pneumonia B-cell small lymphocytic lymphoma recurrent Congenital cystic kidney disease Malignant central nervous system neoplasm Thrombocytosis Hypochromic anaemia Transient ischaemic attack Pyruvate dehydrogenase complex deficiency More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Diagnostics Haemophagocytic lymphohistiocytosis – Diagnostics Richter’s syndrome – Trials in Disease Angiosarcoma recurrent – Trials in Disease Myxofibrosarcoma – Treatment Haemolytic uraemic syndrome Fragile X syndrome – Basic Information Shprintzen-Goldberg syndrome – Treatment Mucopolysaccharidosis II – Diagnostics Phenylketonuria More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Prasugrel Glatiramer Acetate Tipiracil Hydrochloride Aclidinium Bromide Etelcalcetide Terbinafine Hydrochloride Tolinapant Lactate Pimavanserin Tartrate Lerodalcibep Nitrofurantoin OMEGA-3-ACID ETHYL ESTERS 90 Venetoclax Oxygen Ph.eur. Botaretigene Sparoparvovec ANOC-001 Itepekimab Naltrexone Hydrochloride Belantamab Mafodotin Ht-29-A Lbl-007 More therapies…

    Learn about Your Condition

    Peripheral artery thrombosis Round cell liposarcoma Nodal osteoarthritis C3 glomerulopathy Chondrocalcinosis Intestinal obstruction Pancreatic carcinoma recurrent Erectile dysfunction Infantile apnoea Fibromyalgia Ovarian cancer Lysosomal storage disorder Renal cancer metastatic Cardiac failure congestive Venous thrombosis limb More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on Eteplirsen for Patients with Duchenne Muscular Dystrophy with Deletion Mutations Amenable to Exon 51 Skipping

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Eteplirsen
    Czechia Denmark France Germany Greece Hungary +7

  • Study Comparing Allogeneic and Autologous Mesenchymal Stem Cells with Hyaluronic Acid for Patients with Knee Osteoarthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Allogeneic Adult Human Mesenchymal Stem Cells Ex-Vivo Expanded
    • Autologous Bone Marrow-Derived Mesenchymal Stem Cells
    • Sodium Hyaluronate
    Spain

  • Study of Prednisolone and SPI-62 for Patients with Polymyalgia Rheumatica

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Clofutriben
    • Prednisolone
    Germany Poland

  • Study on the Safety and Efficacy of Empasiprubart for Adults with Dermatomyositis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatomyositis
    Investigated Drugs:
    • Empasiprubart
    Greece Italy Poland Spain

  • Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Resiniferatoxin
    • Ropivacaine Hydrochloride
    Bulgaria Poland Romania

  • Study on the Effects of Sonelokimab for Patients with Active Axial Spondyloarthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Sonelokimab
    Germany
Previous Page
1 … 48 49 50 51 52 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!